Navigation Links
New chemo drug gentler on fertility, tougher on cancer
Date:3/22/2013

CHICAGO --- A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.

The scientists designed a quick new in vitro test that predicts the toxicity of a chemotherapy drug to fertility and can be easily used to test other cancer drugs in development as well as existing ones. Currently the testing of cancer drugs for fertility toxicity is a time and resource intensive process.

"Our overall goal is to create smart drugs that kill the cancer but don't cause sterility in young women," said Teresa Woodruff, a co-principal investigator of the study and chief of fertility preservation at Northwestern University Feinberg School of Medicine. The paper was published March 20 in in the journal PLOS ONE.

The scientists hope their integration of drug development and reproductive toxicity testing is the beginning of a new era in which chemotherapy drugs are developed with an eye on their fertotoxity (fertility toxicity). As cancer survival rates increase, the effect of cancer treatments on fertility is critically important to many young patients.

Woodruff and Thomas O'Halloran, also a co-principal investigator and director of the Chemistry of Life Processes Institute at Northwestern, are a wife and husband team who developed and tested the drug. Their intersecting interests -- hers in fertility preservation, his in cancer drug development -- percolated over dinner conversations and sparked the collaboration.

O'Halloran also is the associate director for basic sciences research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Woodruff is the Thomas J. Watkins Memorial Professor of Obstetrics and Gynecology at Feinberg. Richard Ahn, now a fou
'/>"/>

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Changes to DNA on-off switches affect cells ability to repair breaks, respond to chemotherapy
2. New way to kill lymphoma without chemotherapy
3. Neutrons help explain why antibiotics prescribed for chemotherapy cause kidney failure
4. Researchers reveal a chemo-resistant cancer stem cell as cancers Achilles heel
5. Scientists uncover strategy able to dramatically reduce chemotherapys side effects
6. New biomarker for common lung cancer predicts responses to chemotherapy
7. Nanobubbles plus chemotherapy equals single-cell cancer targeting
8. Harmless human virus may be able to boost the effects of chemotherapy
9. Our coral reefs: In trouble - but tougher than we thought
10. New study highlights strong anti-cancer properties of soybeans
11. St. Jude Childrens Research Hospital announces issuance of US patent for cancer therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Long before humans figured out how to create colors, ... bright butterfly wings of many different hues, for example. ... a more environmentally friendly way to make colored plastics. ... and architectures of materials rather than dyes, to ... Letters . , N. Asger Mortensen, Anders Kristensen and ...
(Date:7/30/2014)... Chown has been awarded the Scientific Committee on ... Antarctic Research. , SCAR, an inter-disciplinary international science ... scientific research in the Antarctic region, and on ... Earth system. The organisation also provides scientific advice ... for governing the region. , The medal is ...
(Date:7/30/2014)... pieces is still in its infant stage. But it ... major significance. "Amazingly often, we are findingin addition to ... we found in Baltic amber," explained Bonn paleontologist Professor ... from the Baltic Sea region, which is almost 10,000 ... the coastal regions of Mecklenburg, Poland and Belarus. The ...
Breaking Biology News(10 mins):Chinese mosquitos on the Baltic Sea 2
... is establishing itself as a global leader in forming a ... the city,s plans to adapt to the challenges and opportunities ... report of the New York City Panel on Climate Change ... York Academy of Sciences , outline the measures the city ...
... COLD SPRING HARBOR, N.Y. (Tues., June 1, ... most important and frequently used techniques in RNA analysis. ... by size and quality assessment. Gels are involved ... primer extension, footprinting and analyzing processing reactions. The ...
... 1, 2010 - Elsevier Properties SA announces the winners ... currently studying for a PhD or having completed a ... recognizes research excellence in the fields of organic, organometallic ... after the prize was launched in January 2010. Submissions ...
Cached Biology News:How New York City is preparing for climate change 2How New York City is preparing for climate change 3Electrophoresis of RNA, avian imaging featured in June's Cold Spring Harbor Protocols 2The Reaxys Ph.D. Prize awards innovative research in organic, organometallic and inorganic chemistry 2The Reaxys Ph.D. Prize awards innovative research in organic, organometallic and inorganic chemistry 3
(Date:7/30/2014)... STONY BROOK, NY (PRWEB) July 30, 2014 ... (OTCQB: APDN), (Twitter: @APDN), a biotechnology firm that provides ... Dr. Michael E. Hogan, Ph.D. Vice President of Life ... in mid-September. , Dr. Hogan will lead ... to form business relationships with biotech and healthcare customers, ...
(Date:7/30/2014)... Fla. , July 30, 2014  Dyadic ... biotechnology company whose patented and proprietary technologies are ... and other proteins for the bioenergy, bio-based chemical, ... appointment of Thomas "Tom" Dubinski as Vice President ... for leading the financial and information technology operations ...
(Date:7/30/2014)... July 30, 2014 NCERC at ... will present his findings on corn stover pretreatment ... this week in Washington, D.C. , “Arun’s ... conference is a testament to the success of ... said. “Thanks to the foresight and vision of ...
(Date:7/30/2014)... LayerBio, Inc., an MIT spinoff developing novel ... of seed financing from friends and family investors. Proceeds ... a novel sustained-release product for ophthalmology. , "We are ... commitment to this important work," said Dr. Ken Mandell, ... many areas in which innovations in drug delivery have ...
Breaking Biology Technology:Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 2NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 3
... Feb. 28 As the leading distributor ... a business,partnership with Spectra Intelligence which allows ... market analyses through the,MarketResearch.com website., The ... world,easy access to complete product descriptions and ...
... Seeks Exclusion Order Barring Importation of CryoCath,s Cryoablation ... Inc. (Nasdaq:,CRYO), a medical device company focused on ... has filed a formal complaint with the,United States ... has engaged in unfair trade practices by infringing ...
... (Nasdaq: KOSN ) today reported financial results for the,quarter ... the quarter and year ended December 31, 2007 were $9.5,million ... to $4.6,million and $29.5 million, or $0.13 and $0.88 per ... were $5.6 million and $22.7 million for the quarter and ...
Cached Biology Technology:MarketResearch.com Announces Distribution of Spectra Intelligence Research 2CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement 2CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement 3Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook 2Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook 3Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook 4Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook 5Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook 6
...
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
...
... Signets Xylene Resistant (X/R) Red ... Chromogen, X/R Red Activator and X/R ... reacts with alkaline phosphatase to produce ... mounted. ,Kit Contains:, , Buffer, ...
Biology Products: